Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-25-297513
Filing Date
2025-11-25
Accepted
2025-11-25 16:45:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 apvo-2025-424b4_-_eloc2.htm 424B4 373141
2 GRAPHIC img31054343_0.jpg GRAPHIC 6733
3 GRAPHIC img31054343_1.jpg GRAPHIC 14823
  Complete submission text file 0001193125-25-297513.txt   404144
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-290663 | Film No.: 251522179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)